Medtronic plc
NYSE:MDT · New York Stock Exchange
+$0.75 today
Vol 8.26M · Avg 11.36M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $1.1B |
| Short-term Investments | $7.2B |
| Receivables | $87.0M |
| Inventory | -$803.0M |
| Other Current | $16.4B |
| Total Current Assets | $24.1B |
| PP&E (Net) | -$1.4B |
| Goodwill | $41.9B |
| Intangible Assets | $10.3B |
| Long-term Investments | $1.4B |
| Other Non-current | $15.2B |
| Total Non-current Assets | $67.4B |
| Total Assets | $91.5B |
Analysis
Selected assets total $91.5B for Latest. The largest visible component is Goodwill at $41.9B, about 45.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.2B +72.7% | $1.3B -16.8% | $1.5B -58.5% | $3.7B +3.4% | $3.6B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $6.7B +0.4% | $6.7B +4.8% | $6.4B -6.5% | $6.9B -5.1% | $7.2B | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $6.5B +6.3% | $6.1B +2.2% | $6.0B +8.1% | $5.6B +1.6% | $5.5B | $533.8M | $399.4M | -$1.7B |
| Inventory | $5.5B +5.0% | $5.2B -1.4% | $5.3B +14.7% | $4.6B +7.0% | $4.3B | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $2.9B +10.6% | $2.6B +6.6% | $2.4B +4.6% | $2.3B +18.6% | $2.0B | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $23.8B +8.6% | $21.9B +1.2% | $21.7B -6.0% | $23.1B +2.3% | $22.5B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $6.8B +11.5% | $6.1B +10.1% | $5.6B +2.9% | $5.4B +3.7% | $5.2B | $1.2B | $1.5B | $687.8M |
| Goodwill | $41.7B +1.8% | $41.0B -1.1% | $41.4B +2.3% | $40.5B -3.5% | $42.0B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $11.7B -11.8% | $13.2B -10.9% | $14.8B -4.8% | $15.6B -12.1% | $17.7B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $7.6B -1.0% | $7.7B +3.6% | $7.4B +16.0% | $6.4B +14.2% | $5.6B | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $67.9B -0.3% | $68.0B -1.8% | $69.3B +2.0% | $67.9B -3.7% | $70.5B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $91.7B +1.9% | $90.0B -1.1% | $90.9B -0.0% | $91.0B -2.3% | $93.1B | $13.3B | $11.9B | $10.6B |
| Account Payables | $2.4B +1.6% | $2.4B -9.5% | $2.7B +17.0% | $2.3B +8.1% | $2.1B | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $2.9B +164.1% | $1.1B +8253.8% | $13.0M -99.7% | $3.7B +186700.0% | $2.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $1.3B +58.3% | $840.0M +19.3% | $704.0M +61.8% | $435.0M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $2.5B +5.9% | $2.4B +21.9% | $1.9B -8.2% | $2.1B -14.5% | $2.5B | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $12.9B +19.4% | $10.8B +19.2% | $9.1B -27.0% | $12.4B +45.7% | $8.5B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $25.6B +7.2% | $23.9B -1.7% | $24.3B +19.5% | $20.3B -22.8% | $26.3B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $403.0M -21.7% | $515.0M -27.3% | $708.0M -19.9% | $884.0M -14.0% | $1.0B | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $4.5B +4.0% | $4.3B -16.5% | $5.2B +12.4% | $4.6B -17.2% | $5.6B | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $30.5B +6.2% | $28.8B -4.8% | $30.2B +16.9% | $25.9B -21.6% | $33.0B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $43.4B +9.8% | $39.6B +0.7% | $39.3B +2.7% | $38.3B -7.8% | $41.5B | $14.7B | $3.7B | $9.6B |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $31.5B +3.5% | $30.4B +0.0% | $30.4B +0.5% | $30.3B +5.8% | $28.6B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$4.3B -29.1% | -$3.3B +5.2% | -$3.5B -54.5% | -$2.3B +35.0% | -$3.5B | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | -$1.0M | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $232.0M +12.6% | $206.0M +13.2% | $182.0M +6.4% | $171.0M -1.7% | $174.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $48.3B -4.3% | $50.4B -2.4% | $51.7B -2.0% | $52.7B +2.2% | $51.6B | $9.1B | $7.7B | $3.3B |
| Total Debt | $28.5B +14.0% | $25.0B +2.7% | $24.4B +1.0% | $24.1B -8.6% | $26.4B | $724.2M | $410.6M | $399.4M |
| Net Debt | $26.3B +10.8% | $23.7B +4.0% | $22.8B +11.9% | $20.4B -10.5% | $22.8B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$125.48B
Stryker Corporation
NYSE:SYK
$119.05B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$114.73B
Bristol-Myers Squibb Company
NYSE:BMY
$110.00B
GSK plc
NYSE:GSK
$101.86B
Sanofi
NASDAQ:SNY
$101.42B
McKesson Corporation
NYSE:MCK
$87.79B
HCA Healthcare, Inc.
NYSE:HCA
$83.31B
Boston Scientific Corporation
NYSE:BSX
$67.32B
Edwards Lifesciences Corporation
NYSE:EW
$49.89B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does MDT have?
Medtronic plc (MDT) reported $2.22B in cash and equivalents in fiscal 2025.
How much debt does MDT carry?
Medtronic plc (MDT) reported $28.52B of total debt, with net debt of $26.30B.
Explore More
Continue the stock analysis
Jump to another research area for this company.